Cardiac troponin in hospitalized COVID-19 patients: Incidence, predictors, and outcomes
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · 2024
DOI: 10.1177/00045632231216599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2024. Verfasst von Praveen Gupta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India. Hauptthemen laut MEDLINE: COVID-19, Hospital Mortality, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
The incidence, predictors, and association of cardiac troponin with mortality in hospitalized COVID-19 were not adequately studied in the past and were also not reported from an Indian hospital.
Methods
In this retrospective cohort study, the cardiac troponin of 240 hospitalized COVID-19 patients was measured. The incidence, predictors, and association of elevated cardiac troponin with in-hospital mortality were determined among hospitalized COVID-19 patients.
Results
The cardiac troponin was elevated in 12.9% (31/240) of the patients. The troponin was elevated in the patients in the older age group (64 years vs. 55 years, p = .002), severe COVID-19 illness (SpO2 < 90%) (93.5% vs. 60.8%, p < .001), low arterial oxygen saturation (SpO2) (80% vs. 88%, p = .001), and low PaO2/FiO2 ratio ( p < .0001). The patients with elevated cardiac troponin had elevated total leukocyte counts (TLC) ( p = .001), liver enzyme ( p = .025), serum creatinine ( p = .011), N-terminal-Pro Brain natriuretic peptide ( p < .0001), and d-dimer ( p < .0001). The majority of the patients with elevated cardiac troponin were admitted to the intensive care unit (90.3% vs. 51.2%; p < .0001), were on a ventilator (61.3% vs. 21.5%; p < .0001), and had higher mortality (64.5% vs. 19.6%; p < .0001). The Kaplan–Meir survival analysis showed that the patients with elevated troponin had worse survival ( p log-rank
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
- Department of Anesthesia and Critical Care, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
ORCID-Profile: Praveen Gupta
Zitieren
APA
Gupta, P., Gupta, A., Bansal, S., & Balakrishnan, I. (2024). Cardiac troponin in hospitalized COVID-19 patients: Incidence, predictors, and outcomes. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. https://doi.org/10.1177/00045632231216599
Vancouver
Gupta P, Gupta A, Bansal S, Balakrishnan I. Cardiac troponin in hospitalized COVID-19 patients: Incidence, predictors, and outcomes. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 2024. doi:10.1177/00045632231216599
BibTeX
@article{Gupta2024,
author = {Gupta, Praveen and Gupta, Anunay and Bansal, Sandeep and Balakrishnan, Ira},
title = {Cardiac troponin in hospitalized COVID-19 patients: Incidence, predictors, and outcomes},
journal = {Annals of Clinical Biochemistry: International Journal of Laboratory Medicine},
year = {2024},
doi = {10.1177/00045632231216599}
}
EUVIMED